BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22418038)

  • 1. Management and prognosis of endometrioid borderline tumors of the ovary.
    Uzan C; Berretta R; Rolla M; Gouy S; Fauvet R; Darai E; Duvillard P; Morice P
    Surg Oncol; 2012 Sep; 21(3):178-84. PubMed ID: 22418038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
    Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
    Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of synchronous endometrial disorders in women with endometrioid borderline tumors of the ovary.
    Jia SZ; Zhang JJ; Yang JJ; Xiang Y; Liang Z; Leng JH
    J Ovarian Res; 2018 Apr; 11(1):30. PubMed ID: 29673382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial ovarian tumors of borderline malignancy: long-term follow-up.
    Casey AC; Bell DA; Lage JM; Fuller AF; Nikrui N; Rice LW
    Gynecol Oncol; 1993 Sep; 50(3):316-22. PubMed ID: 8406194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrioid Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Managements.
    Ricotta G; Maulard A; Candiani M; Scherrier S; Genestie C; Pautier P; Leary A; Chargari C; Mangili G; Morice P; Gouy S
    Ann Surg Oncol; 2022 Sep; 29(9):5894-5903. PubMed ID: 35590116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
    Cao DY; Shen K; Tao T; Yang JX; Xiang Y; Huang HF; Wu M; Pan LY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
    Suh-Burgmann E
    Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneously detected endometrial and ovarian carcinomas--a prospective clinicopathologic study of 74 cases: a gynecologic oncology group study.
    Zaino R; Whitney C; Brady MF; DeGeest K; Burger RA; Buller RE
    Gynecol Oncol; 2001 Nov; 83(2):355-62. PubMed ID: 11606097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
    Kennedy AW; Hart WR
    Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrioid epithelial ovarian cancer : 20 years of prospectively collected data from a single center.
    Storey DJ; Rush R; Stewart M; Rye T; Al-Nafussi A; Williams AR; Smyth JF; Gabra H
    Cancer; 2008 May; 112(10):2211-20. PubMed ID: 18344211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors predicting recurrence in borderline ovarian tumors.
    Wu TI; Lee CL; Wu MY; Hsueh S; Huang KG; Yeh CJ; Lai CH
    Gynecol Oncol; 2009 Aug; 114(2):237-41. PubMed ID: 19481786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
    Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
    Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronous endometrioid tumors of the ovary and endometrium. A clinicopathologic study of 22 cases.
    Falkenberry SS; Steinhoff MM; Gordinier M; Rappoport S; Gajewski W; Granai CO
    J Reprod Med; 1996 Oct; 41(10):713-8. PubMed ID: 8913971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
    Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
    Soliman PT; Slomovitz BM; Broaddus RR; Sun CC; Oh JC; Eifel PJ; Gershenson DM; Lu KH
    Gynecol Oncol; 2004 Aug; 94(2):456-62. PubMed ID: 15297188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation.
    Lininger RA; Ashfaq R; Albores-Saavedra J; Tavassoli FA
    Cancer; 1997 May; 79(10):1933-43. PubMed ID: 9149020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative surgery for borderline ovarian tumors: a review.
    Tinelli R; Tinelli A; Tinelli FG; Cicinelli E; Malvasi A
    Gynecol Oncol; 2006 Jan; 100(1):185-91. PubMed ID: 16216320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.